Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study

por Iwata, Hiroji, Masuda, Norikazu, Yamamoto, Yutaka, Fujisawa, Tomomi, Toyama, Tatsuya, Kashiwaba, Masahiro, Ohtani, Shoichiro, Taira, Naruto, Sakai, Takehiko, Hasegawa, Yoshie, Nakamura, Rikiya, Akabane, Hiromitsu, Shibahara, Yukiko, Sasano, Hironobu, Yamaguchi, Takuhiro, Sakamaki, Kentaro, Bailey, Helen, Cherbavaz, Diana B., Jakubowski, Debbie M., Sugiyama, Naoko, Chao, Calvin, Ohashi, Yasuo
Publicado 2018

A real-world study of cardiac events in > 3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study

por Lidbrink, Elisabet, Chmielowska, E., Otremba, B., Bouhlel, A., Lauer, S., Liste Hermoso, M., Nüesch, E., Shing, M., Misra, V.
Publicado 2018

Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up

por Rugo, H. S., Finn, R. S., Diéras, V., Ettl, J., Lipatov, O., Joy, A. A., Harbeck, N., Castrellon, A., Iyer, S., Lu, D. R., Mori, A., Gauthier, E. R., Bartlett, C. Huang, Gelmon, K. A., Slamon, D. J.
Publicado 2019

Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses

por Broeckx, Sarah Y., Seys, Bert, Suls, Marc, Vandenberghe, Aurélie, Mariën, Tom, Adriaensen, Edouard, Declercq, Jeroen, Van Hecke, Lore, Braun, Gabriele, Hellmann, Klaus, Spaas, Jan H.
Publicado 2019

Re-interpretation of PAM50 gene expression as quantitative tumor dimensions shows utility for clinical trials: application to prognosis and response to paclitaxel in breast cancer

por Camp, Nicola J., Madsen, Michael J., Herranz, Jesús, Rodríguez-Lescure, Álvaro, Ruiz, Amparo, Martín, Miguel, Bernard, Philip S.
Publicado 2019

Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Rep...

por Szijgyarto, Zsolt, Flach, Koen D., Opdam, Mark, Palmieri, Carlo, Linn, Sabine C., Wesseling, Jelle, Ali, Simak, Bliss, Judith M., Cheang, Maggie Chon U., Zwart, Wilbert, Coombes, R. Charles
Publicado 2019

Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial

por Pijpers, Judith A, Kies, Dennis A, Louter, Mark A, van Zwet, Erik W, Ferrari, Michel D, Terwindt, Gisela M
Publicado 2019

Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study

por Bhatt, Deepak L., Fox, Kim, Harrington, Robert A., Leiter, Lawrence A., Mehta, Shamir R., Simon, Tabassome, Andersson, Marielle, Himmelmann, Anders, Ridderstråle, Wilhelm, Held, Claes, Steg, Philippe Gabriel
Publicado 2019

Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study

por Bunch, T. Jared, Jacobs, Victoria, May, Heidi, Stevens, Scott M., Crandall, Brian, Cutler, Michael, Day, John D., Mallender, Charles, Olson, Jeff, Osborn, Jeffrey, Weiss, J. Peter, Woller, Scott C.
Publicado 2019

Combination Therapy With Zoledronic Acid and FES‐Row Training Mitigates Bone Loss in Paralyzed Legs: Results of a Randomized Comparative Clinical Trial

por Morse, L R, Troy, K L, Fang, Y, Nguyen, N, Battaglino, R, Goldstein, R F, Gupta, R, Taylor, J A
Publicado 2019

Breast sensibility after mastectomy and implant-based breast reconstruction

por Bijkerk, E., van Kuijk, S. M. J., Beugels, J., Cornelissen, A. J. M., Heuts, E. M., van der Hulst, R. R. W. J., Tuinder, S. M. H.
Publicado 2019

Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval

por Poodt, Ingrid G. M., Schipper, Robert-Jan, de Greef, Bianca T. A., Vugts, Guusje, Maaskant-Braat, Adriana J. G., Jansen, Frits H., Wyndaele, Dirk N. J., Voogd, Adri C., Nieuwenhuijzen, Grard A. P.
Publicado 2019

Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study

por Wuerstlein, R., Kates, R., Gluz, O., Grischke, E. M., Schem, C., Thill, M., Hasmueller, S., Köhler, A., Otremba, B., Griesinger, F., Schindlbeck, C., Trojan, A., Otto, F., Knauer, M., Pusch, R., Harbeck, N.
Publicado 2019

Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study

por Lynce, F., Barac, A., Geng, X., Dang, C., Yu, A. F., Smith, K. L., Gallagher, C., Pohlmann, P. R., Nunes, R., Herbolsheimer, P., Warren, R., Srichai, M. B., Hofmeyer, M., Cunningham, A., Timothee, P., Asch, F. M., Shajahan-Haq, A., Tan, M. T., Isaacs, C., Swain, S. M.
Publicado 2019

Two-year follow-up of the OptiTrain randomised controlled exercise trial

por Bolam, Kate A., Mijwel, Sara, Rundqvist, Helene, Wengström, Yvonne
Publicado 2019

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemoth...

por de Groot, A. F., Blok, E. J., Charehbili, A., Engels, C. C., Smit, V. T. H. B. M., Dekker-Ensink, N. G., Putter, H., Meershoek-Klein Kranenbarg, E., van de Velde, C. J. H., Liefers, G. J., Nortier, J. W. R., Kuppen, P. J. K., van der Burg, S. H., Kroep, J. R.
Publicado 2019

Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants

por Evans, D. Gareth R., Harkness, Elaine F., Brentnall, Adam R., van Veen, Elke M., Astley, Susan M., Byers, Helen, Sampson, Sarah, Southworth, Jake, Stavrinos, Paula, Howell, Sacha J., Maxwell, Anthony J., Howell, Anthony, Newman, William G., Cuzick, Jack
Publicado 2019

Wake Forest University long‐term follow‐up of type 2 myocardial infarction: The Wake‐Up T2MI Registry

por Jogu, Hanumantha R., Arora, Sameer, Vaduganathan, Muthiah, Qamar, Arman, Pandey, Ambarish, Chevli, Parag A., Pansuriya, Tusharkumar H., Ahmad, Muhammad I., Dutta, Abhishek, Sunkara, Padageshwar R., Qureshi, Waqas, Vasu, Sujethra, Upadhya, Bharathi, Bhatt, Deepak L., Januzzi, James L., Herrington, David
Publicado 2019

The influence of neoadjuvant chemotherapy on complications of immediate DIEP flap breast reconstructions

por Beugels, J., Meijvogel, J. L. W., Tuinder, S. M. H., Tjan-Heijnen, V. C. G., Heuts, E. M., Piatkowski, A., van der Hulst, R. R. W. J.
Publicado 2019

Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone

por Sestak, Ivana, Martín, Miguel, Dubsky, Peter, Kronenwett, Ralf, Rojo, Federico, Cuzick, Jack, Filipits, Martin, Ruiz, Amparo, Gradishar, William, Soliman, Hatem, Schwartzberg, Lee, Buus, Richard, Hlauschek, Dominik, Rodríguez-Lescure, Alvaro, Gnant, Michael
Publicado 2019